Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol

Rosalind Adam* (Corresponding Author), Saravanakumar Kanakarajan, Uzunma Onyeakazi, Malachy Columb, Helen Galley

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)
7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences